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ABSTRACTSResults: The cohort comprised of 19 men and 23 women. The mean age of
patients was 53.23 years. Theywere all unilateral adrenalectomies. Twenty
were left sided procedures and twenty twowere right sided. The diagnoses
were Conn's syndrome in 18 patients, Cushing's syndrome in 4 patients,
Non-functioning adenoma in 11 patients, Pheochromocytoma in 5 pa-
tients, Metastatic lesions in 2 patients. The average tumour size was
34.65mm. The mean operating timewas 95.36minutes. The mean hospital
stay was 4.4 days. One patient required intraoperative blood transfusion.
The morbidity rate was 19% (n¼8). There was no mortality. The open
conversion rate was 2.38% (n¼1).
Conclusions: Laparoscopic adrenalectomy as conﬁrmed in other pub-
lished series is safe and effective. It involves shorter hospital stay. Com-
plications are mild and mortality rare when experienced surgeons are
involved.
0180: TESTICULAR TORSION: A COMPARATIVE AUDIT OF OPERATIVE
PRACTICES IN SOUTH YORKSHIRE
Marcus Cumberbatch 2, Gemma McKenzie 2, Hanif Shiwani 1. 1Barnsley
District General Hospital, South Yorkshire, UK; 2Royal Hallamshire Hospital,
South Yorkshire, UK.
Introduction: Acknowledged by the European Association of Urologists,
there is no set guideline for the operative approach in patients presenting
with the Urological emergency testicular torsion.
Methods: We use recommendations from a paper by Pearce et al 2002 to
compare the practices of General Surgeons at a District General Hospital, and
Urological Surgeons fromaCentral TeachingHospital. Bestpractice in all cases
of testicular torsion included bilateral ﬁxation at 3 points or more, with non-
absorbable sutures, and concomitant excision of the testicular appendage. In
all cases of negative exploration orchidopexy was not advocated.
Results: Our ﬁndings in 69 cases from two hospitals over a two-year
period show that operative practices are similar between the disciplines
and we are matching the recommendations. However, a high proportion
of negative explorations are still resulting in ﬁxation, which is not
required. A higher proportion of General Surgeons are using absorbable
sutures.
Conclusions: Surgical trainees are in front line to receive this emergency
and there is a need to provide a national guideline to set standards and
ensure best patient care. We are constructing an intranet operative
guideline on scrotal exploration for trainees.
0195: OUR INITIAL EXPERIENCE OF MINIMALLY INVASIVE SURGERY
(LAPAROSCOPIC AND ROBOTIC) IN THE MANAGEMENT OF SMALL
RENAL MASSES
Karen Randhawa, Robin Weston, Philip Cornford. Royal Liverpool University
Hospital, Merseyside, UK.
Aims: For patients with primary tumour less than 4cm, nephron sparing
surgery is preferred to preserve renal parenchyma and function thereby
decreasing the risk of chronic kidney disease. We reviewed our surgical
outcomes following NSS by laparoscopic and robot techniques.
Method: Retrospective review of 12 consecutive patients who underwent
NSS between 2010 and 2012 for renal tumours (laparoscopic and robotic)
were included in the study. Data collected included tumour size, renal
function pre/post surgery, histology and disease free data. Complications
were recorded using Clavien-Dindo classiﬁcation.
Results: Most procedures were robot-assisted, while four were performed
laparoscopically. Median PADUA score was 6.5 with average tumour size of
2.65cms. Warm ischaemia time varied from zero to twenty-two minutes,
with mean length of stay 2.6 days for robotic and 4.65 days for laparoscopic
surgery. Preoperatively average eGFR was 77ml/min/1.732, with post-
operative average of 76ml/min/1.732. 2 patients encountered Grade 1 com-
plications and 2 of Grade 2. 92% of patients had negative surgical margins.
Conclusions: Robot NSS appears to be a safe and technically feasible
approach with shorter length of stay than other operative methods. These
early results suggest good surgical outcomes with reduced perioperative
morbidity and preservation of renal function achievable by minimally
invasive NSS.
0207: THE BENEFICIAL EFFECTS OF ENHANCED RECOVERY PROTOCOL
FOR PATIENTS UNDERGOING RADICAL CYSTECTOMYMohammed Ashraﬁ, Garwi Choy, Mohammed Masaarane. Lancashire
Teaching Hospitals NHS Foundation Trust, Preston, UK.
Aim: Radical Cystectomy is associated with signiﬁcant morbidity and
prolonged inpatient stay. Enhanced recovery protocols (ERP) are periop-
erative care pathways designed to achieve early recovery after surgical
procedures. The aimwas to assess the impact on patient outcome after the
introduction of an ERP for the management of patients undergoing radical
cystectomy.
Method: An ERP was introduced in our hospital and 60 consecutive pa-
tients between March 2010 and February 2012 were compared (ERP¼32
and non-ERP¼28). The primary outcome measures were duration of
inpatient stay, morbidity and mortality. Data were analyzed retrospec-
tively from hospital records.
Results: There was a statistically signiﬁcant reduction in the length of
hospital stay for patients in the ERP group (mean¼16) in comparison to the
non-ERP group (mean¼25; p ¼ 0.016). There was increase rate of post
operative ileus in the non-ERP group (12 vs 6), however this was not
statistically signiﬁcant. The 30 day mortality rate for all groups was 0%.
Conclusions: The introduction of an ERP was associated with signiﬁcantly
reduced hospital stay, with no detrimental effect on morbidity or
mortality.
0217: THE USE OF UROVAXOM IN TREATMENT OF RECURRENT URI-
NARY TRACT INFECTION
Kieran Murphy, Sheilagh Raid. Royal Hallamshire Hospital, Shefﬁeld Teaching
Hospitals, Shefﬁeld, UK.
Acute uncomplicated cystitis is treated with short-term antibiotic therapy,
however recurrent urinary tract infection (UTI) can be a disabling condi-
tion associated with signiﬁcant morbidity.
Aim: We looked at using Urovaxom in reducing frequency of urinary
tract infections. Urovaxom is an oral vaccine containing lyophilized
bacterial lysates of Escherichia coli, for treatment of urinary tract
infections.
Method: We performed retrospective case note review of patients who
received Urovaxom over a 2 year period. Initially given as a 3 month
course, with further doses taken during and for 10 days following an acute
episode of UTI; in conjunction with traditional antibiotic therapy. We are
the ﬁrst UK centre licensed to use this product.
Results: In a group of 10 patients who have used Urovaxom, there was
signiﬁcant improvement in 5 patients, with some improvement in a
further 2 patients. In those patients where symptoms improved there was
less use of antibiotic therapy and perceived improvement in quality of life.
Conclusions: Initial work has shown that in patients with difﬁcult to treat
symptoms, Urovaxom may be beneﬁcial as an adjunct to traditional
treatment, in reducing the number of infections. European Association of
Urology (EAU) guidelines reﬂect this in female patients, although a
consensus is not yet available in males
0268: PATIENT EDUCATION: ARE WE DOING ENOUGH TO ENABLE THEM
TO IMPROVE THEIR OWN OUTCOMES?
Emma Upchurch, Edward Jefferies, Kim Davenport. Cheltenham General
Hospital, Cheltenham, UK.
Aim: Venous thromboembolism (VTE) is a preventable postoperative
complication. The hypercoagulable state following surgery remains for at
least 28 days, thus, prophylaxis should continue to cover this period. The
aim of this audit is to determine if patients are completing the course of
prophylaxis on discharge and, if not, the reasons for this.
Method: Patient compliance and reasons for non-compliance was deter-
mined via retrospective telephone questionnaire for patients who had
undergone major urological surgery between February and May 2012.
Results: 72% of patients were prescribed the appropriate length of VTE
prophylaxis. Of these, only 20% of patients completed the course. The main
reason for failure was lack of understanding.
Conclusion: Despite adequate prescribing, patients failed to complete the
recommended course of prophylaxis, thus, placing them at increased risk
of VTE. The majority of patients did not understand the reasons and, thus,
stopped the 28 day course early. They reported limited information from
medical staff regarding the beneﬁts (and risks) of continuing VTE pro-
phylaxis for 28 days. This audit did not measure the incidence of VTE,
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ABSTRACTShowever, previous studies have shown reduced incidence with extended
prophylaxis. One can infer that improving patient understanding and,
thus, compliance will reduce the incidence of postoperative VTE.
0282: RE-RESECTION TURBT RATE IN PATIENTS WITH HIGH GRADE
BLADDER CANCERS
Michelle Christodoulidou, Jeremy Oates, Karuppana Mohan Pillai. Royal
Blackburn Hospital, Blackburn, East Lanchashire Hospitals Trust, UK.
Aim: Transurethral Re-resection of Bladder Tumour base is often necessary
in high grade tumours to ensure correct staging, especially when no
muscle is present in the initial histological sample. We reviewed the
number of new TURBT performed in the Trust over 12 months and the re-
resection rate for lack of muscle or poor quality specimen.
Method: Retrospective Collection of data was performed from patients
with new bladder cancer diagnosis from 1/9/11 until 31/8/12. All cases that
required re-resection were isolated as a group.
Results: 143 new TURBT were performed in our Trust and in total 25 re-
resections. Most common disease re-resected was G3PT1 and G3PTa with
or without CIS. 21 re-resections (14.7%) were performed due to lack of
muscle or poor quality specimen. Upstaging of disease was present in 16%
(4 cases) in this group. 76% of the cases that needed re-resection, the initial
resections were performed by Trainees.
Conclusions: Early re-resection is signiﬁcantly important in patients with
high grade tumours where correct staging cannot be ensured. Although
our re-resection rate is lower than that in existing literature (22%)
we must ensure that deep muscle is provided in the ﬁrst resected
specimen.
0289: CLINICAL AND FINANCIAL BENEFITS OF RESTRICTED AGAINST
LIBERAL FLUID ADMINISTRATION DURING RADICAL PROSTATECTOMY
Sarvpreet ubee, Matthew Rooney, Mahamad Al-Hahme,
Ramasamy Jaganathan, Pitabas Mishra. The Heart of England NHS Trust,
Birmingham, UK.
Aim: To assess the clinical and ﬁnancial beneﬁts of "Liberal or standard"
(LFA) to "Restricted" (RFA) ﬂuid administration during open radical pros-
tatectomy (ORP)
Materials and Methods: Retrospectively 108 patients who underwent
ORP were identiﬁed. Twenty-three patients were eligible for clinical data
collection in each group. Case note review was done and two groups were
compared with a paired t- test. Potential savings were calculated based on
the collected data by comparing the RFA against LFA. Fluid restriction
protocol was agreed for the RFA group.
Results: In LFA group the mean age was 64.6, weight 79.1kg, ASA1 - 10,
ASA2 - 11 and 21pts had epidural, while for RFA group 64yrs, 81.3kg, ASA1
- 11, ASA2 - 9 and epidural in 18pts. The intraoperative blood loss(p<0.05),
hemoglobin drop(p<0.05) and number of blood transfusions(p<0.05) was
less in the RFA group and statistically signiﬁcant alongwith change in
H+concentration and base excess (p<0.05). The total cost saving with RFA
is £14340 (£623/case) accounting form reduced blood transfusion, crys-
talloid and colloid use and reduces hospital stay.
Conclusion: Restriction of ﬂuid in perioperative period was found to be
superior to the standard ﬂuid management in this cohort of patient un-
dergoing Radical Prostatectomies and was ﬁnancially favourable.
0337: PREDICTING IMMEDIATE LEVEL OF CARE REQUIREMENT
FOLLOWING RADICAL CYSTECTOMY e AUDIT OF OUTCOME
Chrysoula Fragkopoulou, Gavish Munbauhal, Stephen Webber,
Sheila M. Reynolds, Ruth Groves, Patrick E. Cutinha, James W.F. Catto,
Mark D. Haynes, David R. Yates, Jo Buck, Derek J. Rosario. Shefﬁeld
Teaching Hospitals, Shefﬁeld, UK.
Introduction: It is standard practice for patients undergoing radical cys-
tectomy (RC) to be pre- booked for a critical care unit (CCU) bed. This study
aimed to examine early outcomes of RC with regards to requirement for
CCU-speciﬁc intervention.
Methods and Patients: 160 consecutive patients undergoing RC be-
tween November 2010 and May 2012 were reviewed. Associations be-
tween pre- and peri-operative parameters and requirement for CCU
interventions were examined. Patients were classiﬁed as Group A if CCU
stay was  24 hours AND required no intervention or Group B if CCUstay was >24 hours and/or required vasopressor, respiratory or renal
support.
Results: Complete data were available on 124 patients to-date. Median
inpatient stay was 13 days. 30 day mortality was 1.3%. Median CCU stay
was 21.7 hours. 69 patients were in Group A and 55 in Group B. In logistic
regression, age, gender, BMI, ASA grade, Lee Cardiac Risk Index, tumour
stage, urinary diversion, intra-operative vasopressor, intra-operative
transfusion, duration of anaesthesia and blood loss did not predict
outcome.
Conclusions: The majority of RC patients do not require CCU- speciﬁc
intervention. Pre-operative features are unable to identify patients at risk.
Prospective evaluation of more procedure-speciﬁc risk scores as predictors
is required.
0391: TREATMENT OF POST PROSTATECTOMY MALE URINARY INCONTI-
NENCE WITH THE ADVANCE MALE SLING: AN EARLY EXPERIENCE
Gemma McKenzie, Felicity Reeves, Sheilagh Reid. Royal Hallamshire
Hospital, Shefﬁeld, UK.
Introduction: The AdVance male sling has been shown to have
durable outcomes at 3 years for the treatment of post prostatectomy
incontinence.
We represent our single centre experience of the AdVancemale sling and
compare the clinical outcomes with those of the larger case series.
Method: Incontinence was assessed on the basis of pad usage. Sub-
jective results were evaluated using two validated condition speciﬁc
QoL tools, the ICIQ-LUTSqol and ICQ-UI Short Form (Copyright  ICIQ
Group), completed by men before and six weeks following surgery.
Objective results were evaluated using the patients reported pad
usage.
Results: Objective improvement was demonstrated in 80% (4/5) of men.
Complete cure (no pad usage) was demonstrated in 20% (1/5), with a
further 60% (3/5) being signiﬁcantly improved (1-2 pads per day). 20% (1/
5) showed no improvement. The ICIQ-LUTS QoL score showed a signiﬁcant
decrease from a pre-sling median value of 143 (IQR: 129-165) to a post-
sling median value of 61 (IQR: 45-74), highlighting the dramatic QoL
improvement in this group of patients.
Conclusion: The AdVance male sling represents a safe and effective
minimally invasive surgical treatment option for post prostatectomy uri-
nary incontinence, and is accompanied by signiﬁcantly improved QoL.
0428: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: A RETROSPEC-
TIVE STUDY OF ELECTIVE TREATMENT FOR URETERIC STONES
Sheena Patel, Ali Panah, Junaid Masood. Barts and the London, London, UK.
Introduction: Extracorporeal shockwave lithotripsy (ESWL) is a non-
invasive method of stone fragmentation. Although less successful at lower
frequencies, higher frequencies can cause tissue damage. There is no
guidance on shockwave administration or frequency of sessions. This
study assesses efﬁciency of elective ESWL in ureteric stones.
Methods: A 15-month retrospective study of 65 patients with ureteric
stones treated by ESWL was completed.
Result: Treatment times were 68, 96 and 119 days for stones less than
5mm, 5-7mm and greater than 7mm respectively. ESWL success rates
were 92%, 94% and 68% for stones less than 5mm, 5-7mm and greater
than 7mm respectively. Passage rates following one session were 67%
for stones less than 5mm, 71% for 5-7mm and 45% for greater than
7mm; Rates related to location were 43% in the PUJ; 69% for proximal
ureter; 57% for mid, 72% for distal and 59% for VUJ. 8% of stones less
than 5mm required laser following failed ESWL, versus 32% greater than
7mm.
Conclusion: PUJ, mid-ureteric and VUJ stones have lower passage rates
than proximal and distal stones. Larger stones at these locations should be
considered for early laser treatment to avoid prolonged treatment, reduce
hospital visits and increase patient satisfaction.
0429: IS POSSUM A VALID RISK ASSESSMENT MODEL FOR PREDICTING
OUTCOMES OF MAJOR UROLOGICAL SURGERY?
Aaron Farrell, Richard Stephenson. Wirral University Teaching Hospital,
Merseyside, UK.
Introduction/Aim: NHS requirements for transparency and accountability
in surgical outcomes require accurate and fair means of measuring
